High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies
Abstract HIV broadly neutralizing antibodies (bnAbs) have been widely studied, and inducing a robust broadly neutralizing response remains a goal for many human vaccine studies. Much research focusses on creating higher affinity antigens to target bnAb precursors, however this ignores the role of no...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Portfolio
2026-05-01
|
| Col·lecció: | npj Vaccines |
| Accés en línia: | https://doi.org/10.1038/s41541-026-01468-y |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|